{"id":4936,"date":"2025-10-27T10:13:01","date_gmt":"2025-10-27T07:13:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4936"},"modified":"2025-10-30T13:22:59","modified_gmt":"2025-10-30T10:22:59","slug":"avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis\/","title":{"rendered":"Avidity Biosciences \u5c06\u88ab\u8bfa\u534e\u6536\u8d2d"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Avidity Biosciences \u6b63\u5728\u5f00\u53d1\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u5916\u663e\u5b50 44 \u8df3\u8dc3\u7597\u6cd5\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u5df2\u4e0e\u8bfa\u534e\u516c\u53f8\uff08\u201c\u8bfa\u534e\u201d\uff09\u8fbe\u6210\u6700\u7ec8\u5408\u5e76\u534f\u8bae\uff0c\u8be5\u534f\u8bae\u5df2\u83b7\u5f97\u4e24\u5bb6\u516c\u53f8\u8463\u4e8b\u4f1a\u7684\u4e00\u81f4\u6279\u51c6\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u6b64\u6b21\u6536\u8d2d\u5c06Avidity\u5c06\u5176\u65e9\u671f\u7cbe\u51c6\u5fc3\u810f\u75c5\u5b66\u9879\u76ee\u5265\u79bb\u81f3SpinCo\uff0cSpinCo\u9884\u8ba1\u5c06\u6210\u4e3a\u4e00\u5bb6\u4e0a\u5e02\u516c\u53f8\u3002SpinCo\u5c06\u7531Avidity\u73b0\u4efb\u9996\u5e2d\u9879\u76ee\u5b98\u51ef\u745f\u7433\u00b7\u52a0\u62c9\u683c\u5c14\uff08Kathleen Gallagher\uff09\u62c5\u4efb\u9996\u5e2d\u6267\u884c\u5b98\u3002Avidity\u73b0\u4efb\u9996\u5e2d\u6267\u884c\u5b98\u838e\u62c9\u00b7\u535a\u4f0a\u65af\uff08Sarah Boyce\uff09\u5c06\u62c5\u4efb\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u8bfa\u534e\u5c06\u6536\u8d2d Avidity \u5728\u795e\u7ecf\u79d1\u5b66\u9886\u57df\u7684\u9879\u76ee\u548c\u7814\u53d1\u7ba1\u7ebf\uff0c\u5e76\u83b7\u5f97\u5176\u5dee\u5f02\u5316\u7684 RNA \u9776\u5411\u9012\u9001\u5e73\u53f0\u3002\u8be5\u534f\u8bae\u6db5\u76d6\u4e09\u4e2a\u540e\u671f\u4e34\u5e8a\u5f00\u53d1\u9879\u76ee\uff1a\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7 (DMD) \u7684 delpacibart zotadirsen (del-zota)\u3001\u7528\u4e8e\u6cbb\u7597 1 \u578b\u5f3a\u76f4\u6027\u808c\u8425\u517b\u4e0d\u826f\u75c7 (DM1) \u7684 delpacibart etedesiran (del-desiran) \u4ee5\u53ca\u7528\u4e8e\u6cbb\u7597\u9762\u80a9\u80b1\u578b\u808c\u8425\u517b\u4e0d\u826f\u75c7 (FSHD) \u7684 delpacibart braxlosiran (del-brax)\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u4e86\u89e3\u66f4\u591a<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/zh\/del-zota-dmd-rna-therapy-from-avidity-biosciences-reverses-the-progression-of-disease\/\">Avidity Biosciences \u7684 Del-Zota DMD RNA \u7597\u6cd5\u53ef\u9006\u8f6c\u75be\u75c5\u8fdb\u5c55<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Avidity Biosciences, which is developing an exon 44 skipping therapy for Duchenne muscular dystrophy, announced that it has entered into a definitive merger agreement with Novartis AG (&#8220;Novartis&#8221;) which has been unanimously approved by the Boards of Directors of both companies. The acquisition will follow the separation of Avidity&#8217;s early-stage precision cardiology programs into SpinCo, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4938,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[126,141,127,246,447],"class_list":["post-4936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-avidity-biosciences","tag-exon-44","tag-exon-44-skipping","tag-exon-44-skipping-therapies","tag-novartis"],"subtitle":"\u8bfa\u534e\u516c\u53f8\u5df2\u540c\u610f\u6536\u8d2d Avidity Biosciences\uff0c\u4ee5\u52a0\u5f3a\u5176\u540e\u671f\u795e\u7ecf\u79d1\u5b66\u7814\u53d1\u7ba1\u7ebf\uff0cAvidity Biosciences \u6b63\u5728\u5f00\u53d1\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u5916\u663e\u5b50 44 \u8df3\u8dc3\u7597\u6cd5\u3002.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=4936"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/4938"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=4936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=4936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=4936"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}